+20.1%
GSK vs SNY
-4.5%
+24.6%
-19.3%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | SNY | Excess | Alpha |
|---|---|---|---|---|
| 1D | 0.0% | +0.1% | -0.1% | 0.0% |
| 7D | -3.5% | -3.3% | -0.2% | -1.8% |
| 30D | -3.4% | -2.2% | -1.3% | -2.2% |
| 3M | -8.1% | -3.0% | -5.1% | -6.8% |
| 6M | -11.1% | +2.7% | -13.9% | -11.9% |
| YTD | +0.7% | -6.8% | +7.6% | +3.2% |
| 1Y | +20.1% | -5.3% | +25.4% | +20.0% |
| All | +20.1% | -4.5% | +24.6% | +20.0% |
Cumulative growth
Daily Returns
Daily percentage return beside SNY.
Daily Out/Under-Performance
Portfolio return minus SNY return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × SNY return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded SNY wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling